TY  - GEN
AU  - Rolfo,Christian
AU  - de Vos-Geelen,Judith
AU  - Isambert,Nicolas
AU  - Molife,L Rhoda
AU  - Schellens,Jan H M
AU  - De Grève,Jacques
AU  - Dirix,Luc
AU  - Grundtvig-Sørensen,Peter
AU  - Jerusalem,Guy
AU  - Leunen,Karin
AU  - Mau-Sørensen,Morten
AU  - Plummer,Ruth
AU  - Learoyd,Maria
AU  - Bannister,Wendy
AU  - Fielding,Anitra
AU  - Ravaud,Alain
TI  - Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment
SN  - 1179-1926
PY  - 2020///0902
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Female
KW  - Humans
KW  - Kidney
KW  - physiopathology
KW  - Male
KW  - Metabolic Clearance Rate
KW  - drug effects
KW  - Middle Aged
KW  - Neoplasms
KW  - complications
KW  - No-Observed-Adverse-Effect Level
KW  - Phthalazines
KW  - administration & dosage
KW  - Piperazines
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Renal Insufficiency
KW  - etiology
KW  - Safety
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s40262-019-00754-4
ER  -